Law Offices of Howard G. Smith Announces Investigation of Allos Therapeutics, Inc.

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Allos Therapeutics, Inc. ( “Allos” or the “Company”) (NASDAQ:ALTH) related to the Company’s agreement to be acquired by Amag Pharmaceuticals in a proposed transaction where Allos shareholders will receive 0.1282 per share of Amag stock.

The investigation concerns whether the board of directors of Allos breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction. Under the terms of the agreement Allos shareholders will receive approximately $2.44 per share, however analysts have recently released price targets for Allos that value the company’s stock between $3.00 and $8.00 per share.

If you are a shareholder of Allos, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Historical Stock Chart
From May 2024 to Jun 2024